Breast Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
特長
-
Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more.
-
Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
著者情報
| ISBN Number | 9780443181856 |
|---|---|
| Description Author List | Edited by Harold J. Burstein, MD, PhD, Professor of Medicine, Harvard Medical School, Staff Physician, Brigham And Women's Hospital |
| Copyright Year | 2023 |
| Edition Number | 1 |
| Format | Book |
| Trim | 152w x 229h (6.00" x 9.00") |
| Imprint | Elsevier |
| Page Count | 240 |
| Publication Date | 29 Nov 2022 |
| Stock Status | IN STOCK |
eBooks : Built for busy schedules & tailored for your goals.
Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.
Seamless access wherever you are
Always in sync
Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.
2. Sign into or create your VitalSource account and redeem your code.
3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Disparities in Breast Cancer Outcomes and How to Resolve Them
Testing for Inherited Susceptibility to Breast Cancer
Breast Cancer Pathology in the Era of Genomics
Breast Cancer Pathology in the Era of Genomics
Role of Ovarian Suppression in Early Premenopausal Breast Cancer
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Biology and Treatment of HER2-Low Breast Cancer
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Multidisciplinary Management of Brain Metastasis from Breast Cancer
Systemic Therapy for Hereditary Breast Cancers
Evidence-Based Guidance for Breast Cancer Survivorship
